Digital PCR of CHIP and MR for MRD Monitoring After Allo-HSCT in AML — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Digital PCR of CHIP and MR for MRD Monitoring After Allo-HSCT in AML — Stella

Home/Acute Myeloid Leukemia (AML)/

View on ClinicalTrials.gov

Recruiting

Back to Acute Myeloid Leukemia (AML) trials

Trial locations(1 site)

China

Peking University People's Hospital, Beijing, Beijing Municipality

Key details

Sponsor

Peking University People's Hospital

Enrollment target

~100 participants

Started

March 2026

Primary completion

December 2027

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.